Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö,...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E.
Target Price
The average target price of ACARIX.ST is 0.40 and suggests 54% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
Buy
Sell